Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis-Reference-Cited by-同舟云学术

Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis

Published:2004-09 Issue:25-26 Volume:22 Page:3475-3486
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Villari P,Manzoli L,Boccia A

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference49 articles.

1. WHO. Influenza vaccines. WHO position paper. Weekly Epidemiol Rec 2002;77(28):230–9.

2. WHO. Preparing for the next influenza season in a world altered by SARS. Available at: www.who.int/csr/don/2003_07_03/en. Accessed October 25, 2003.

3. Influenza vaccine enlisted to prevent SARS confusion;Schlagenhauf;Lancet,2003

4. The efficacy of influenza vaccine in elderly persons. A meta-analysis and a review of the literature;Gross;Ann. Int. Med.,1995

5. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community;Vu;Vaccine,2002

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic Analysis Reveals Sixteen Potential Genes Associated with the Successful Differentiation of Antibody-Secreting Cells through the Utilization of Unfolded Protein Response Mechanisms in Robust Responders to the Influenza Vaccine;Vaccines;2024-01-29

2. Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults;Expert Review of Vaccines;2023-10-06

3. Transcriptomic Analysis Reveals Potential Genes and Essential Biological Processes Controlling the Robust Immune Response to Trivalent Inactivated Influenza Vaccine in Healthy Adults;2023-08-30

4. Association between physical activity and immunogenicity of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases;Brain, Behavior, and Immunity;2022-03

5. Comparing machine and human reviewers to evaluate the risk of bias in randomized controlled trials;Research Synthesis Methods;2020-03-03